NEW YORK--(BUSINESS WIRE)-- Deutsche Bank today announced its appointment as depositary bank for the Level I American Depositary Receipt (ADR) program of Japan-based Daiichi Sankyo Company, Ltd. (Daiichi Sankyo). Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical products to address the diversified, unmet medical needs of patients in both mature and emerging markets. Daiichi Sankyo does business in nearly 60 countries around the world, with world headquarters in Tokyo, Japan.
